Penn State University

The Charles River Lab in Germantown, MD, stands as a hub of scientific exploration and innovation. Nestled in a quiet corner of the city, this laboratory plays a crucial role in advancing research and development across various fields. Equipped with state-of-the-art technology and staffed by skilled professionals, it serves as a dynamic space where ideas come to life. From conducting intricate experiments to analyzing complex data, the Charles River Lab is a melting pot of intellectual curiosity and discovery. Researchers here delve deep into the realms of biology, chemistry, and beyond, pushing the boundaries of knowledge. With a commitment to excellence and a passion for progress, this laboratory remains at the forefront of cutting-edge research, shaping the future of scientific endeavors. Generated using this place's available information

GlycoMimetics is a late clinical-stage biotechnology company based in Gaithersburg, MD, specializing in the discovery and development of glycobiology-based therapies for cancers and inflammatory diseases. Their lead candidate, uproleselan, is currently in pivotal Phase 3 development for relapsed refractory acute myeloid leukemia (AML) and in a Phase 2/3 trial for newly diagnosed AML patients fit for chemotherapy. Uproleselan has received Breakthrough Therapy and Fast Track designations from the U.S. FDA for the treatment of adult AML patients with relapsed or refractory disease. As a pioneer in glycobiology, GlycoMimetics utilizes their proprietary chemistry platform and extensive understanding of the role carbohydrates play in cell recognition to discover innovative medicines that aim to improve patient outcomes. The company has established significant collaborations with leading academics, governmental organizations, and pharmaceutical biotechnology companies to drive their proprietary programs forward.Generated from the website